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Background: Osteomyelitis is a devastating condition whose treatment relies on the detection of bacteria. The
current standard of microbiology culture may not be adequate. Molecular biology based diagnostic procedures for
detecting bacteria in orthopaedic infections was previously established, but has not been applied to the setting of
chronic osteomyelitis. We aim to determine the applicability of molecular diagnostic procedures for monitoring
chronic osteomyelitis, and to evaluate if these procedures are superior to standard culture methods of osteomyelitis
detection.
Methods: A rabbit experimental model of chronic osteomyelitis was used; infection was induced in the proximal,
medial aspect of the tibia with Staphylococcus aureus at titers ranging from 1 × 102 to 1 × 106 colony forming units.
At 28 days post-infection, animals were sacrificed, and the tibias were examined radiographically, harvested, and
assayed for the presence of bacteria. Two bacterial detection methods were used: (1) standard microbiological
culturing, and (2) polymerase chain reaction (PCR) based diagnostic method to detect bacterial genomic DNA.
Results: The molecular diagnostic method was highly sensitive and accurate, and detected low titer infections that
were undetected by radiographic and microbiological methods. By using two sets of PCR primers, one for a
universal bacterial gene (16S rRNA) and one for a species-specific gene (nuc), the molecular protocol allowed both
the detection and speciation of the bacterial infection.
Conclusions: The use of the PCR-based method was effective for high-sensitivity detection and identification of
bacteria associated with chronic osteomyelitis in a rabbit model. Our findings illustrate the applicability of PCR for
monitoring chronic osteomyelitis, which may be useful for improved detection of osteomyelitis organisms in
humans.
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Chronic osteomyelitis is a significant source of patient
morbidity in both pediatric and adult populations [1,2].
The successful management of the disease is critically
dependent on the timely and accurate diagnosis of infec-
tion as the etiology of the symptoms, and the ability to
monitor effective antimicrobial or other curative therap-
ies. Early detection of bacterial infiltration in bone, when
bacterial titers are low and when standard diagnostic* Correspondence: rst13@pitt.edu
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in any medium, provided the original work is ptests may be equivocal early in the infection cycle [3],
could allow for more effective treatments to be instituted
sooner to achieve bacterial infection eradication in osteo-
myelitis. However, standard culture methods may not be
very effective for detecting orthopaedic infections [4].
Previous studies in our laboratory and others have dem-
onstrated the superior sensitivity and accuracy of molecu-
lar biological technology, based on the DNA amplification
technique of polymerase chain reaction (PCR); [5,6]) and
for the detection of infection in symptomatic arthroplasty
patients (Mariani et al. 1996b; [7-12]). Our recent studies
and those of others have further refined molecular tech-
niques to access bacterial viability in simulated and clinical
infections [13-16]. Many other clinical fields are also de-
veloping protocols utilizing nucleic acid based methodsan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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For orthopaedics, enhanced diagnostics for infectious dis-
eases could play a significant role in treating infections, es-
pecially in cases where the diagnosis of infection is not
straightforward, such as fracture nonunions [21], painful
prosthetic joints (Mariani et al. 1996b), loose prosthetic
joints [22], certain arthritic conditions [23], and osteomye-
litis subsequent to bone trauma [24] or as a result of sec-
ondary infection from hematogenous sources.
A number of animal models have been developed to
investigate the pathogenesis of osteomyelitis and the effi-
cacy of various antibiotic treatment regimens [25,26].
Previously, our laboratory has used the rabbit experi-
mental osteomyelitis protocol developed by Norden [27]
to test the effectiveness of a biodegradable carrier for the
local delivery of antibiotics to the site of infection in a
fracture stabilization model [28-30]. In these studies,
chronic infection was routinely established in 14 to 28 days
using an inoculum of 1 × 106 colony forming units (CFU)
of Staphylococcus aureus (strain 23923, American Type
Culture Collection, Manassas, VA).
In the present study, we sought to use the experimental
osteomyelitis model in rabbits [27] to test the effectiveness
of the PCR-based molecular diagnostic assay, particularly
in detecting low level of infection in the early stages of dis-
ease progression. In this study, we addressed the follow-
ing questions: (1) Is the molecular diagnostic procedure
applicable for monitoring chronic osteomyelitis?; and
(2) Does molecular diagnostic perform better than cul-
ture methods for osteomyelitis detection?Methods
Experimental chronic osteomyelitis
Experimental osteomyelitis was induced in rabbits using
Staphylococcus aureus (strain 23923, American Type
Culture Collection, Rockville, MD) according to the
protocol of Norden [27].Bacterial growth
Bacteria were grown overnight under aerobic conditions
in tryptic soy broth at 37°C, concentrated by centrifuga-
tion, washed, and resuspended in a one sixth volume of
sterile physiological saline. Bacterial concentration was
estimated spectrophotometrically on the basis of optical
density at 600 nm (1 OD600 unit = 1 × 109 cells/mL).
Additionally, CFU titers of suspension were verified by
plating aliquots from a ten-fold dilution series on tryptic
soy agar plates in duplicate and counting colonies after
overnight growth at 37°C. Bacterial suspensions of 1 × 106,
1 × 104, 1 × 103, and 1 × 102 CFU/0.1 ml were prepared by
serial dilution, and 0.1 ml of each concentration was used
for injection into the medullary cavity of rabbit tibias pre-
pared as described below.Animal procedure
Approval was obtained from the Institutional Animal Care
and Use Committee (Thomas Jefferson University IACUC)
(Protocol 234 J) prior to performing this study. New
Zealand White rabbits weighing 2–3 kg were anesthetized,
their left tibias shaved and cleaned with alcohol, and the
bone exposed by a small incision. An 18 gauge needle was
inserted through the medial aspect of the tibia 1–2 cm dis-
tal from the proximal metaphysis to deliver, in order, a
0.1 ml volume of 5% sodium morrhurate as a sclerosing
agent, a 0.1 ml volume of bacterial suspension of appropri-
ate concentration (see above), and a 0.1 ml volume of
sterile saline to facilitate the entry of the mixture into the
medullary cavity, after which the wound was closed.
Animals were administered analgesics postoperatively, and
monitored during the recovery period until their mobility
returned. Those animals displaying signs of discomfort
were given analgesics as necessary. Osteomyelitis was
usually established between 14 and 28 days, depending on
the inoculum titer [31-33]. Animals were sacrificed at
28 days for all inoculum titers.
Experimental osteomyelitis was induced in 15 rabbits using
Staphylococcus aureus at 4 different inoculum titers: 1 × 106
(animals #1,2,3,4), 1 × 104 (#5,6,7,10,11,12,13), 1 × 103 (#14),
and 1 × 102 (#15,16,17) CFU. Three additional animals
were used as negative controls: two animals were mock
infected with the sclerosing agent and saline alone (#8,18),
and 1 animal was not operated on (#9). Animals were
sacrificed at 28 days, and either one (Group 1: Animals #
1-9) or four (Group 2: Animals #10-18) biopsies were ob-
tained from each animal as described below.
Analysis of infection
Infection was analyzed radiographically, as well as using
microbiological and molecular assays. Biopsy of the bone
at the site of infection was performed in one of two
ways. For the first group of 9 rabbits, the operated tibia
was surgically retrieved, dissected free of soft tissue, al-
cohol cleaned, and a biopsy of bone and bone marrow
was recovered from the osteotomy site (where infection
was induced) using a curette. For the remaining animals
(Group 2, 9 animals), four biopsy methods were used. In
addition to the first retrieval of bone at the osteotomy
site as described above, a second bone and bone marrow
biopsy was recovered from the immediate, lateral meta-
physis in a similar manner, to test for the migration of in-
fection to this region. In addition, in this second group of
animals, prior to the biopsy procedure described above,
aspirate samples were taken from both regions (osteotomy
and metaphysis) using a 18 gauge needle to retrieve a
specimen containing both cortical bone and bone mar-
row. All retrieved materials were weighed and divided into
two aliquots and subjected to microbiological culture
and DNA extraction for molecular analysis in parallel.
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Microbiological culture
All biopsy and needle retrieval specimens were homoge-
nized and mixed in 1.0 ml of sterile physiological saline, di-
luted serially in saline in triplicate, and then plated on
tryptic soy agar for colony counts after incubation at 37°C.
Bacterial growth was not assessed quantitatively, since there
was quantitative variability in the recovered specimen.
Molecular diagnosis
DNA extraction was carried out using a previously estab-
lished protocol [6] DNA was extracted from the portion
of the specimen not used for microbiological culture as
follows. The specimen was finely minced with sterile
scissors, added to 0.2 ml extraction buffer containing
100 mM Tris–HCl, pH 8.0, 2 mM EDTA, pH 8.0, 50 mM
KCl, 0.5% (vol/vol) Tween 20, and 0.5% (vol/vol) NP-40,
mixed vigorously by vortexing, and heated to 95°C for
10 minutes. After cooling to room temperature, a mixed
bed ion exchange resin (BioRad AG501-X8, Hercules, CA)
was added to a final concentration of 20% (wt/vol), mixed
by vortexing, cleared by centrifugation for 10 minutes at
10,000 × g, and the supernatant containing the extracted
nucleic acid was transferred to a new tube and stored until
PCR testing.
Polymerase Chain Reaction (PCR)
As described previously [6], PCR was performed on all
specimens using 5 μl of extract in a 50 μl reaction vol-
ume using 0.25 units of AmpliTaq LD DNA polymerase
(Perkin Elmer, Norwalk, CT) per reaction using the
manufacturer’s buffer system according to the manufac-
ture’s specifications. The nucleic acid amplification reac-
tions were performed in a thermocycler (MJ Research
DNA Engine Thermocycler, Watertown, MA) using the
following cycling profile, following a pre-cycle incuba-
tion at 94°C for 4 min: denaturation at 94°C for 1 min,
annealing at 55°C for 1 min, and primer extension at
72°C for 2 min, for 30 cycles, using 50 pmol of each ampli-
fication primer per reaction. Two different primer sets
were used for bacterial detection in this study (Integrated
DNA Technologies, Coralville, IA). The sequences for the
forward and reverse primers for the first set, complemen-
tary to the conserved, multicopy 16S ribosomal ribo-
nucleic acid (rRNA) gene, were 5′-CGGCAGGCCTAA
CACATGCAAGTCG-3′, and 5′-GGTTGCGGCCGTAC
TCCCCAGG-3′, respectively. The sequences for the for-
ward and reverse primers of the second set, complemen-
tary to the Staphylococcus aureus specific heat stable
nuclease gene (nuc), were 5′-5′ GCG ATT GAT GGT
GAT ACG GTT-3′ and 5′ AGC CAA GCC TTG ACG
AAC TAA AGC-3′, respectively. PCR products wereanalyzed by agarose gel electrophoresis and ethidium
bromide staining, followed by membrane blotting and
hybridization analysis using either the [32P]-labelled 16S
rRNA or nuc gene fragment as hybrization probe [34,35].
Comparison of quantitative real-time PCR to PCR
A quantitative evaluation of the DNA-based PCR pro-
cedure used here was also made by comparison with
our recent protocols using real time quantitative PCR
(qPCR) [13,14].
Reagents
DNeasy Blood & Tissue kit was purchased from QIAGEN
(Gaithersburg, MD). SYBR Green PCR Master Mix was
purchased from Invitrogen (Grand Island, NY). PrimeSTAR
HS was purchased from Clontech Laboratories (Mountain
View, CA). 16S rRNA primers were obtained from Integrated
DNA Technologies (forward: 5′-ATTAGATACCCTGGT
AGTCCACGCC-3′; reverse: 5′-CGTCATCCCCACCTT
CCTCC-3′; 387 base-pair amplification product).
Bacterial culture
Escherichia coli HB101 (ATCC 33694) were grown in
LB medium at 37°C and bacterial concentration (cells/mL)
was determined based on OD 600 (1 OD600 unit = 1 × 109
cells/mL). Final bacterium concentration was 1.98 × 109
cells/mL.
DNA isolation
Genomic DNA was extracted from a 5 mL aliquot of
E. coli HB101 culture using the DNeasy Blood & Tissue
kit (QIAGEN). The DNA content was measured (based
on OD 260 nm) and the DNA/cell value was subsequently
used to estimate cell number.
PCR
PCR was performed using the PrimeSTAR HS kit (Clon-
tech Laboratories). Ten-fold serial dilutions of template
DNA were used to generate the standard curve. Fifty μL
of PCR reaction mixture consisted of 10 μL of genomic
DNA (0, 10−4, 10−3, 10−2, 10−1, 1, 101, 102 ng), 4 μL of
2.5 mM dNTP Mixture, 25 μL of primeSTAR buffer,
2.5 μL of 5 μM 16S rRNA primers (mixture of forward
and reverse primers), 0.5 μL of 2.5 units/μL primeSTAR
HS DNA polymerase, and 8 μL of distilled water. The
control sample did not contain genomic DNA. PCR was
performed with the Applied Biosystems Veriti 96 well
Thermal Cycler (Life Technologies, Grand Island, NY)
as follows: 95°C for 4 min.; 35 cycles of 95°C for 20 s,
58°C for 30 s, 72°C for 45 s; 72°C for 5 min; 4°C for in-
finity. After amplification, a 5 μL aliquot of each sample
was directly subjected to gel electrophoresis in 2% agar-
ose gel in the presence of ethidium bromide. Image J
(NIH) was used to quantify the levels of each sample.
Mariani et al. Journal of Experimental Orthopaedics 2014, 1:9 Page 4 of 10
http://www.jeo-esska.com/content/1/1/9All reactions were performed in triplicates using the
same genomic DNA stock.
Quantitative Real-time PCR
qPCR was performed with SYBR Green Master Mix
using ABI StepOne Real-Time PCR Systems (Life Tech-
nologies, Grand Island, NY). Five-fold serial dilutions of
template DNA were used to generate the standard curve.
20 μL of qPCR reaction mixture consisted of 5 μL of
genomic DNA (0, 1.28 × 10−4, 6.4 × 10−4, 3.2 × 10−3,
1.6 × 10−2, 8 × 10−2, 4 × 10−1, 2, 10, 50 ng), and 1 μL of
5 μM 16S rRNA primers (mixture of forward and re-
verse primers), 10 μL of SYBR Green Master Mix, and
4 μL of distilled water. The control sample did not con-
tain genomic DNA. The cycling conditions were 95°C
for 10 min, followed by 45 cycles of 95°C for 10 s ad 60°C
for 30 s. For all samples, the cycle number at which the
fluorescence values became logarithmic (Ct) was deter-
mined. The ΔCt value (sample Ct-control Ct) was calcu-
lated for each sample as the difference between the
sample Ct and control Ct. All reactions were performed in
quadruplicates using the same genomic DNA stock.
Results
Microbiological culture analysis
In Group 1 animals that received a single biopsy, 6 out
of the 7 (86%) experimental animals gave positive micro-
biological cultures (Table 1). For the remaining experi-
mental animals (Group 2) that were tested for infection
using the four biopsy method, 4 of the 8 rabbits pro-
duced at least 1 microbiological culture test that was
positive for bacterial growth, but none tested positive for
all four biopsy methods (Table 2). Of the 4 animals thatTable 1 Rabbit Osteomyelitis (Group 1): comparison of
infection detection methods
Infection detection




1 1 × 106 + + +
2 1 × 106 + + +
3 1 × 106 + + +
4 1 × 106 + + +
5 1 × 104 + + +
6 1 × 104 - + +
7 1 × 104 + + +**
8 Sclerosing agent and
saline only
- - -
9 Unoperated control - - -
*PCR done using 16S rRNA gene primers.
**Positive PCR result obtained after two rounds of extraction of sample with
Mixed Bed Ion Exchange Resin (see text for details).received 1 × 104 CFU inoculations in Group 2, 3 tested
positive in one or more biopsies and 1 tested negative
for bacterial culture growth. The 1 animal that received
a 1 × 103 inoculation was negative. Finally, in 1 of the 3
animals receiving 1 × 102 CFU inoculations, bacterial
growth was detected with 1 biopsy method in 1 animal,
but no growth was detected in the other 2 animals.
No bacterial growth was recovered from the 3 negative
control animals used in this study. In total, of the 15 in-
oculated experimental animals tested, 10 (67%) gave at
least one biopsy that was positive for bacterial infection.
However, in the 39 total microbiological culture tests
performed on the 15 animals, taking into account the
animals with multiple biopsies, only 13 tests were posi-
tive, yielding a 33% sensitivity, assuming infection was
established in all animals at all sites. [Note: Verification
that the bacteria recovered from the culture assays was
Staphylococcus aureus was achieved by PCR amplifica-
tion of DNA extracted from individual colonies from a
representative number of culture plates using the
Staphylococcus aureus-specific nuc gene primers, carried
out as described below. Amplification of the expected
gene fragment in all cases indicated infection was not
due to a secondary infection by commensal, coagulase-,
or nuclease-negative Staphylococci bacteria].
Radiographic analysis
Examination of the radiographs taken from these ani-
mals showed distinct lucency and evidence of bone ero-
sion only in the animals inoculated with 1 × 106 CFU of
bacteria (Animals #1-4, Figure 1A). All other animals
failed to exhibit any overt signs of compromised bone
quality, in a double-blind examination (Figure 1B).
PCR-based molecular analysis
The remaining half of all biopsy materials recovered from
inoculated and control animals was processed for total nu-
cleic acid extraction using a rapid protocol previously de-
scribed for synovial fluid specimens from symptomatic
arthroplasty patients [6]. The presence of bacterial in-
fection was documented by PCR amplification of DNA
recovered from biopsies using primers specific for two dif-
ferent bacterial genes: (1) the bacteria-specific, conserved,
multi-copy 16S rRNA gene; or (2) the Staphylococcus
aureus-specific nuclease (nuc) gene. For the single biopsy
group (Group 1), comprising all animals inoculated with
1 × 106 CFU, and 3 of the animals inoculated with 1 ×
104 CFU of bacteria, the 16S rRNA PCR primers were
used for amplification of bacterial DNA. After agarose gel
electrophoresis and blot hybridization analysis using
cloned 16S rRNA gene fragment as hybridization probe, 6
of the 7 infected animals were positive for infection based
on PCR. The mock inoculated and unoperated negative
control animals were negative using the PCR test.
Table 2 Rabbit Osteomyelitis (Group 2): comparison of infection detection methods
Microbiological culture and PCR*
Metaphysis biopsy Osteotomy biopsy
Needle Curette Needle Curette
Animal no. Titer (CFU) Radiograph Culture PCR Culture PCR Culture PCR Culture PCR
10 1 × 104 + - + + - + + + +
11 1 × 104 + - + + + - + - +
12 1 × 104 + + + - - + + - -
13 1 × 104 + - - - + - + - -
14 1 × 103 - - + - - - + - +
15 1 × 102 - - + - - - - - +
16 1 × 102 - - - - + - + - -
17 1 × 102 - - - + + - - - -
18 Sclerosing agent/saline only - - - - - - - - -
*PCR done using Staphylococcus aureus nuc gene primers.
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mens, which entailed the addition of an internal control
DNA template containing the same 16S primer se-
quences to each amplification reaction mixture to verify
the ability of all extracts to support DNA amplification.
In all cases, except for rabbit #7, positive control prod-
uct was detected from the extracts. This result indicates
that the extract derived from rabbit #7 contained sub-
stances inhibitory to the Taq DNA polymerase enzyme,
and additional processing was required. Since this speci-
men contained a large proportion of whole blood, the
extract was retreated with the ion-exchange mixed bed
resin, and a second round of amplification was performed
and bacterial derived PCR product was subsequentlyFigure 1 Radiographic evaluation of osteomyelitis. (A) A proximal rabb
evidence of osteomyelitis, characterized by lucency and bony erosion. (B) A
demonstrates no evidence of osteomyelitis or bony compromise.detected. This result indicated that infection was evi-
dent and detectable by PCR after additional processing,
and increased the PCR detection sensitivity to 100% (7/7)
for this set of animals.
For Group 2, the animals tested for infection using the
four biopsy method, PCR analysis was performed with
the nuc gene amplification primers to directly establish
Staphylococcus aureus as the infectious agent. In this
group, PCR product was detected from all infected ani-
mals, for either some, or all the biopsy methods. There
was a general correlation between the signal intensity and
number of positive tests per animal, and the concentration
of the initial bacterial inoculation. In 3 of 4 animals receiv-
ing 1 × 104 CFU, and the 1 animal receiving 1 × 103 CFU,it tibia that had been inoculated with 1 × 106 CFU of bacteria exhibits
proximal rabbit tibia that had not been inoculated with bacteria
Figure 3 Gel electrophoresis analysis of PCR product from 16S
rRNA. Ethidium bromide staining indicated sensitivity of detection
to ~50 cells.
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signals for each animal. In the 3 animals receiving
1 × 102 CFU inoculations, only 1 or 2 of the four biopsy
methods used for each animal yielded PCR signal. In total,
25 of the 39 infection tests were positive as determined by
PCR. The usefulness of the Staphylococcus aureus-specific
nuclease (nuc) gene primers in the amplification reaction
was two-fold: first, amplification and detection of bacterial
DNA product indicated infection was indeed present, and
secondly, it allowed the unequivocal determination of
Staphylococcus aureus as the infectious agent.
The detection limits of PCR & qPCR for bacterial 16S
rRNA were next assessed using Escherichia coli DNA
samples extracted from a known bacterial titer. Trad-
itional PCR method based on gel electrophoresis analysis
gave linear standard curve in the concentration range
from 10−4 to 10−1 ng DNA (equivalent to 5.2 × 102 to
5.2 × 105 cells) (Figures 2 and 3), but showed apparent
saturation at higher amounts of DNA (i.e., 1 and 10 ng,
data not shown). In comparison, qPCR method yielded
linear standard curve in the concentration range from
around 10−4 to 10 ng DNA (equivalent to 5.2 × 102 to
5.2 × 107 cells) (Figure 4). Our results therefore showed
that qPCR readily produced quantitative results and
could detect 100 times higher bacteria concentration
without loss of sensitivity or linearity of detection com-
pared to the conventional PCR method.Figure 2 PCR standard curve for 16S rRNA using diluted
Escherichia coli HB101 genomic DNA as a template. Linear
regression fit performed on the standard curve in the concentration
range from 10−5 to 10−1 ng DNA.Comparison of microbiological, radiographic and
molecular analyses
For the animals in the 1 × 106 CFU inoculation group, there
was concordance between all three diagnostic methods.
However, infection testing of the animals in the 1 × 104 or
lower CFU groups showed discordance between the three
methodologies. Microbiological culture assays detected in-
fection in only 5 of 7 animals receiving 1 × 104 CFU inocu-
lations. In the 4 animals of that group that were assayed
using the multiple biopsy methods, only a subset of the bi-
opsies for each animal gave bacterial growth. Radiographic
examinations failed to provide any definitive diagnosis of
infection. On the other hand, in these 1 × 104 CFU in-
oculation animals, the PCR test was positive in all 7 ani-
mals, 3 of which were positive with the four biopsy
method. In the 1 × 103 CFU animal, and the 3 animalsFigure 4 qPCR quantitative analysis of 16S rRNA. E. coli genomic
DNA was used as a template. Linear regression fit performed on the
standard curve in the concentration range from around 10−4 to
10 ng DNA.
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tests were obtained compared to culturing. In these low
titer infections, microbiological culture was positive in
only 1 of 16 biopsies (rabbit #17), compared to 8 positive
PCR results. In only one case (rabbit #10) was there a bi-
opsy positive using microbiological culture, but negative
by PCR, although all other biopsies of that animal were
PCR positive. Overall, the molecular test displayed a sub-
stantially greater sensitivity compared to the microbio-
logical test or radiographic examination, and the results
were available within 24 hours, or less, after specimen
collection.
Discussion
Osteomyelitis continues to be a troublesome infection af-
fecting pediatric patients and adults alike, eliciting fever,
pain, inflammation, and bone degradation and loss, which
sometimes can be fatal if not properly addressed with anti-
microbial, or surgical intervention. Whereas acute osteo-
myelitis subsequent to bone trauma or a surface wound
infection may be readily diagnosed, slowly progressing
chronic osteomyelitis derived from hematogenous sources
often presents a more difficult diagnosis [1,2]. Experimen-
tal osteomyelitis in animals [27,36], for example using the
rabbit model, has been valuable for studying the establish-
ment, progression and treatment of the chronic disease.
Several different protocols have been employed for the in-
duction of chronic osteomyelititis. We have successfully
employed the rabbit model developed by Norden [27] that
uses a sclerosing agent to promote the establishment and
progression of infection. In our previous study [28], the
rabbit model has been used to test the efficacy of a bio-
degradable antibiotic delivery system for the treatment of
bone infection. The success of this model prompted us to
use it to test the efficacy of the protocol we have estab-
lished for infection detection using molecular biology
methodology ([6,8]; Mariani et al. 1996b; [7,13,14]). Ex-
perimental osteomyelitis in this animal model allows the
precise control of infectious dose, progression of disease,
choice of infectious agent, and conditions that are amen-
able for the rigorous testing of new diagnostic strategies.
Thus, the purposes of our study were to determine (1) the
applicability of the molecular diagnostic procedure for
monitoring chronic osteomyelitis, and (2) whether mo-
lecular diagnostic is superior to culture methods of osteo-
myelitis detection.
The molecular test demonstrated excellent sensitivity in
two respects. First, all infected animals were determined
to be positive by PCR, and secondly, infection documenta-
tion was unequivocal in all animals displaying low level
disease. In these latter animals, standard microbiological
and radiographic testing failed to establish either the pres-
ence of bacterial infiltration, or morphological evidence
of pathological involvement of bone. It could be arguedthat these animals might not have had, or were not
going to progress to, established chronic osteomyelitis,
and potentially would have cleared the microorganisms
immunologically, and that the PCR test was detecting
nucleic acid from the original bacterial population in the
inoculum, and not focal disease resulting from pathogenic
proliferation in vivo. However, it is highly unlikely that any
organisms from the inoculum would have remained intact
in a healthy, immunoreactive animal for 4 weeks, without
clearance by the immune system, to result in false positive
PCR results. More plausible is that growth and expansion
of the inoculum bacterial population did occur in these
animals, and that even though classic osteomyelitis
was not fully established based on standard radiographic
evidence (Figure 1), underlying bacterial proliferation and
colonization that would eventually manifest as chronic
disease was indeed taking place, and was in fact detectable
by the more sensitive molecular assay, but not by micro-
biological or radiographic analysis. These findings demon-
strate that the molecular test, if used appropriately in
clinical situations where osteomyelitis is suspected, or
where a definite probability of its development exists be-
cause of the clinical history of the patient, could be a valu-
able diagnostic assay for detecting low bacterial loads in
the early stages of infection, prior to fully developed dis-
ease, at a time when antimicrobial therapy would be the
most effective.
Two different amplification primers strategies have been
used in this study. With one set of animals, the “universal”
16S rRNA gene primers that target a conserved region of
this multi-copy gene unique to bacteria were used for bac-
terial detection. These primers hybridize to the 16S rRNA
gene of essentially all pathogenic bacteria and are useful
for broad spectrum detection of infection in situations
where the infectious agent cannot be easily cultured, or in
infections that can be caused by one of many different
species that all present with similar, indistinguishable
symptoms. Although a predominant number of clinical
osteomyelitis cases in humans are caused by Staphylococ-
cus aureus, other species are routinely isolated, including
Streptococcus pyogenes and other Group A Streptococci,
Hemophilus influenzae, Pseudomonas aeruginosa, Proteus,
Bacteroides, Staphylococcus epidermidis, and others [7].
In previous studies ([6,8]; Mariani et al. 1996b; [7]), we
have demonstrated the usefulness of these 16S rRNA
gene primers for the detection of species from a range of
different genera including some of the species mentioned
above. In this study, we have further shown the abil-
ity of these same primers to document the presence
of Staphylococcus aureus in extracts derived directly
from animal bone biopsies, thereby expanding the poten-
tial application of this technology for tissues and fluids.
With the second set of animals in this study, the species-
specific PCR primers that target the unique, Staphylococcus
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approach allowed not only for the rapid diagnosis of bacter-
ial infection, but also verified that Staphylococcus aureus
was the infectious agent, a situation that simulates the com-
mon conditions of chronic osteomyelitis in humans. In an
analogous manner, the use of species-specific primers tar-
geting other pathogens, such as those mentioned above for
which extensive sequence information is available, would
expand the diagnostic capability of the PCR-based mo-
lecular technology, i.e., the capability of speciation.
Limitations of this study include the small number of
subjects, as this is an animal study. There was also dis-
cordance in findings for animals with low levels of infec-
tion. For the animals inoculated with 1 × 106 CFU of
bacteria, there was complete correlation between radio-
graphic, microbiological and molecular testing. However,
for animals receiving 1 × 104 CFU inoculations, discord-
ance between the different assays was observed. Whereas
radiographic and molecular testing successfully identified
all infected animals in the set, microbiological testing was
negative in 2 of 7 animals. In one of the rabbits, #13, no
bacterial outgrowth was detected in any of the four biopsy
specimens from the osteotomy site or from the adjacent
metaphysis; on the other hand, the PCR test yielded
at least one positive test from each site. For the animals
that received the lower titer inocula, i.e., 1 × 103 or 1 ×
102 CFU, and developed early stage disease, microbio-
logical testing had a particularly poor success rate. Only 1
of 4 animals gave a positive bacteriological culture test; in
fact, of the 16 specimens obtained with the different bi-
opsy methods, only 1 test was positive. The molecular
methodology gave 8 positive tests from the same set
of biopsies, including from the 1 specimen that was
determined to be positive microbiologically. Of all the ex-
perimental animals, there was only one case (rabbit #10)
in which a biopsy specimen from an infected animal gave
a positive microbiological culture, and a negative PCR test;
however, the three remaining biopsies from the same ani-
mal were positive by PCR, indicating unequivocally that
this animal was indeed infected. Radiographic assessment
was at best ambiguous in these animals with mild, low-
level infection. Additionally, in the laboratory setting, sam-
ple processing is available immediately after biopsying
tissue samples. In the clinical setting, it is recommended
to biopsy all bone suspicious for osteomyelitis (cortical
bone, cancellous bone, and medullary canal) and send it
off for immediate processing on the same day as sampling.
If immediate processing is not possible, we recommend
that tissue samples be stored at 4°C to minimize bacterial
growth and proliferation.
Conclusion
Taken together with our previous studies ([6,8]; Mariani
et al. 1996b; [7,13,14]), the findings reported here suggestthe following practical approach to applying the PCR
amplification technology for the diagnosis of infectious
diseases. PCR and qPCR based testing with universal
primers is to be used as the first screen of clinical speci-
mens to identify those samples containing bacterial DNA,
regardless of species, to alert the clinician that infection is
highly probable in those patients testing positive. The
limitation of PCR is that speciation is not possible
and can limit antibiotic susceptibility data. A second
round of amplification may then be performed on the
positive specimens identified in the first screen, using
an adequate number of multiplex amplification reac-
tions employing multiple, species-specific primer sets,
each corresponding to suspected pathogens as a means of
species identification. Finally, as suggested by our recent
refinements of the PCR test, the viable bacteria load may
be assessed using a reverse-transcription based PCR proto-
col that targets viability-sensitive bacterial mRNAs [14]
and 16S rRNA [13].
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